Overview
FDA & Trial Timeline
1 eventSandostatin LAR: FDA approved
Treatment of profuse watery diarrhea associated with VIPoma.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Metabolic disease associated with ocular features.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Metabolic disease associated with ocular features at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Metabolic disease associated with ocular features.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesSandostatin LAR
Novartis Pharmaceuticals Corporation
Travel Grants
No travel grants are currently matched to OBSOLETE: Metabolic disease associated with ocular features.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Metabolic disease associated with ocular features.
Start the conversation →Latest news about OBSOLETE: Metabolic disease associated with ocular features
No recent news articles for OBSOLETE: Metabolic disease associated with ocular features.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Metabolic disease associated with ocular features
What treatment and support options exist for OBSOLETE: Metabolic disease associated with ocular features?
1 patient support program are currently tracked on UniteRare for OBSOLETE: Metabolic disease associated with ocular features. See the treatments and support programs sections for copay assistance, eligibility, and contact details.